Open AccessSaxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
Author(s) -
Priscilla Hollander,
Jia Li,
Elsie Allen,
Roland Chen,
for the CV- Investigators
Publication year - 2009
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-0550
Subject(s) - saxagliptin , glycemic , medicine , thiazolidinedione , type 2 diabetes , pioglitazone , postprandial , endocrinology , rosiglitazone , diabetes mellitus , gastroenterology , insulin , sitagliptin
Due to the natural progression of type 2 diabetes (T2D), most patients require combination therapy to maintain glycemic control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom